CN Patent

CN105596304B — 用于减缓周边血管疾病病患间歇性跛行症状的属喹啉酮衍生物的西洛他唑的新颖调配物

Assigned to GENOVATE BIOTECHNOLOGY CO Ltd · Expires 2020-10-16 · 6y expired

What this patent protects

一种用于减缓周边血管疾病病患间歇性跛行症状的属喹啉酮衍生物的西洛他唑的新颖调配物。一种呈固体形式的药学组合物，其含有微粒状西洛他唑(cilostazol)或其盐类、纤维素、稀释剂及润滑剂。该药学组合物有特征在于西洛他唑的活体内血浆轮廓为C 24h /C max ＞0.25。亦揭露有一种制备上述药学组合物的方法。

USPTO Abstract

一种用于减缓周边血管疾病病患间歇性跛行症状的属喹啉酮衍生物的西洛他唑的新颖调配物。一种呈固体形式的药学组合物，其含有微粒状西洛他唑(cilostazol)或其盐类、纤维素、稀释剂及润滑剂。该药学组合物有特征在于西洛他唑的活体内血浆轮廓为C 24h /C max ＞0.25。亦揭露有一种制备上述药学组合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN105596304B
Jurisdiction
CN
Classification
—
Expires
2020-10-16
Drug substance claim
No
Drug product claim
No
Assignee
GENOVATE BIOTECHNOLOGY CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.